NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE American · Medical Devices · USD

Picard Medical, Inc. (PMI) Stock Analysis

Picard Medical, Inc. (PMI) is a Medical Devices stock listed on NYSE American and quoted in US Dollar.

PMI

$4.56

+$0.07 (+1.56%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PMI with… →

PMI Key Statistics

As of Sep 4, 2026
Trading
Open
$4.46
Previous Close
$4.49
Day's Range
4.35–5.35
52-Week Range
2.65–684.00
Volume
509.30K
Valuation
Market Cap
$9.37M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.49
EPS (ttm)Profit attributable to each share over the last twelve months.
−36.37
Financials (FY)
Revenue (FY)
$4.94M+12.50%
Net Income (FY)
−$27.00M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
2.05M
1-Year Return
−98.41%
Dividend and dates
Avg Volume
1.68M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

PMI Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−94.79%
2025 (partial year)−61.87%

As of September 4, 2026.

PMI Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$4.94M−$27.00M−546.6%
2024$4.39M−$21.06M−479.5%
2023$5.04M−$15.57M−308.7%
2022$4.11M−$11.17M−271.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$4.94M−$204.00K−$13.26M−$27.00M−546.6%
2024$4.39M−$112.00K−$13.71M−$21.06M−479.5%
2023$5.04M−$2.31M−$15.50M−$15.57M−308.7%
2022$4.11M−$4.99M−$11.07M−$11.17M−271.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PMI Valuation vs Medical Devices Median

Median of 151 stocks
MetricPMIMedical Devices medianvs median
P/S ratio1.492.9850% below
Profit margin0.00%−1.69%1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Picard Medical, Inc. (PMI) is capitalised at $9.37M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 75 employees.

PMI last closed at $4.56 on September 4, 2026. That is +$0.07 (+1.56%) against the previous close. The 52-week range on file runs from $2.65 to $684.00. The latest close sits 71.95% above that 52-week low.

Financial Health

In fiscal 2025, Picard Medical, Inc. reported revenue of $4.94M. Against the prior fiscal year total of $4.39M, that is a change of +12.50%. The same year closed with a net loss of $27.00M. The reported profit margin is 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −36.37.

Across the 4 fiscal years on file, revenue moves from $4.11M in 2022 to $4.94M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 1.49 times revenue. On price-to-sales that is 50.05% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned −98.41%. Daily returns over the trailing 1 year annualize to a volatility of 214.69%.

Growth & Income

The record shows no dividend for PMI.

2026 is still running; the price is −94.79% year to date.

Peer Comparison

Picard Medical, Inc. (PMI) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Picard Medical, Inc. PMI $9.37M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Picard Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Picard Medical, Inc.

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.

Visit website →